Dimed S.A. Distribuidora de Medicamentos reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was BRL 4,461.02 million compared to BRL 3,990.48 million a year ago. Net income was BRL 92.91 million compared to BRL 86.35 million a year ago.

Basic earnings per share from continuing operations was BRL 0.62 compared to BRL 0.58 a year ago. Diluted earnings per share from continuing operations was BRL 0.62 compared to BRL 0.58 a year ago.